NABH Cracks Down on Fake Docs: Hospitals under Scrutiny

The National Accreditation Board for Hospitals and Healthcare Providers (NABH) has restated its zero-tolerance policy

Steriline debuts agile, flexible filler at Pharmintech 2025

Steriline, a company highly specialised in the production of complete aseptic packaging lines for injectables and ophthalmic products for global pharmaceutical companies, will participate...

Meril Presents Successful LANDMARK RCT One-Year Results at Prestigious EuroPCR 2025

Meril Life Sciences today announced one-year results from its pivotal LANDMARK trial, presented during the prestigious Late-Breaking Trial session at EuroPCR 2025, one of the world’s premier cardiology conferences held annually in Paris, France.

Lupin Licenses Biosimilar Ranibizumab for Latin American Markets

Lupin pharmaceutical announced that it has entered into a license and supply agreement with SteinCares for the commercialization of biosimilar ranibizumab throughout all of Latin America...

Syngene Targets Brain Biomarker to Boost Anxiety Drug Research

In the developing side of drug development for mood and anxiety disorders, Syngene has stressed the critical need to precisely measure

Dr Reddy's API Unit in Telangana Gets 2 USFDA Observations

After a close inspection of its active pharmaceutical ingredient (API) manufacturing unit, Dr. Reddy’s Laboratories has received a Form 483 with two observations from the US Food and Drug Administration (USFDA)...

XTANDI Extends Survival in Metastatic Hormone-Sensitive Prostate Cancer

Astellas Pharma and Pfizer have reported new updated long-term results from the open-label extension portion of the Phase 3 ARCHES study that utilized a five-year follow-up to demonstrate continued overall survival (OS) benefits...

Lincoln Pharmaceuticals reports Net Profit of Rs. 82.44 crore

Lincoln Pharmaceuticals Limited, one of India's leading healthcare companies has reported a standalone net profit of Rs. 82.44 crore for the FY25 ended March 2025 as against net profit of Rs. 93.37 crore FY24.

Delhi Govt Issues Advisory to Hospitals Amid Rise in COVID Cases

Due to the recent increase in COVID-19 cases, the Delhi government has issued advisory commending hospitals to raise preparedness,

Alembic Gets USFDA Approval for generic high blood pressure treatment drug

Alembic Pharmaceuticals has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Amlodipine and Atorvastatin Tablets USP...

© 2025 India Pharma Outlook. All Rights Reserved.